Anti VTE Prophylaxis in Medical Patients with Severe Renal Failure – A Survey of Practice Trends and Opinions of UK Nephrologists

Reducing venous thromboembolism (VTE) in hospitalised patients is a national priority. However, the evidence of benefit from pharmacological and mechanical thromboprophylaxis in unwell medical patients is marginal. Many of the randomised clinical trails have often omitted patients with severe renal failure and many of the drugs used have limited evidence of efficacy amongst this patient group. We know that low molecular weight heparins accumulate over time and that renal patients often have complex clotting disturbances particularly when unwell. This is especially challenging for inpatients who require ongoing anticoagulation during dialysis. A clinical trial is long overdue to answer the question of, what is the optimal VTE prevention strategy, balancing the benefit of reducing VTE incidence and minimising the risk of adverse events?

This short Web-based survey is designed to survey current practice trends and opinions amongst UK Nephrologists regarding the use of anti VTE prophylaxis in medical patients with severe renal impairment. The completion of this survey will help shape the context of a large multicentre study designed to answer the question of what is the optimum anti-VTE strategy for our renal patients?

The survey should take less than 5 minutes to complete and I would be very grateful for your participation.

Please note the deadline to complete the survey is Thursday 9 August 2012.

Dr Chris Goldsmith
Renal Consultant
University Hospital Aintree

Email: christopher.goldsmith@aintree.nhs.uk